Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.

Schools Push to Get Students Vaccinated Before the Start of Academic Year

WSJ reported:

With the start of school only weeks away in some parts of the country, schools, school districts and some teachers unions are pushing to get students vaccinated to ensure they are inoculated against the spread of COVID-19 when classes fully reopen in the fall.

Sixty-three percent of public schools were open full-time, in-person for all students by May, while 2% offered remote learning exclusively, according to data released Thursday from the U.S. Department of Education’s Institute of Education Sciences. Many districts are planning on reopening in the fall for in-person instruction, although some will still also offer remote learning.

“The time is now” for vaccinations, said Jim Blumenstock, the senior vice president of pandemic response and recovery at the Association of State and Territorial Health Officials. “The school year is right around the corner, depending on [the] part of the country.”

FDA to Add Warning to J&J Vaccine of ‘Serious But Rare’ Autoimmune Disorder

The Defender reported:

The U.S. Food and Drug Administration (FDA) is planning to announce a new warning on Johnson & Johnson’s (J&J) COVID vaccine saying the shot has been linked to Guillain–Barré syndrome (GBS), a “serious but rare” autoimmune disorder. The Washington Post attributed the news to “four individuals familiar with the situation.”

According to The New York Times, the chances of developing GBS after receiving the J&J shot is three to five times higher than would be expected in the general population in the U.S.

CDC Says Kids Can Get COVID and Flu Vaccines at the Same Time — But Where’s the Safety Study?

The Defender reported:

The CDC’s Advisory Committee on Immunization Practices (ACIP) recently unanimously voted 14-0 to coadminister the COVID-19 and flu vaccine to adults and children. The proposed policy for the 2021-2022 influenza season was made to implement changes that coincide with the timing of children returning to school in fall 2021, and to align with the CDC’s guidelines allowing COVID-19 vaccines to be coadministered with other vaccines.

This also will be the first influenza season where nearly all available flu vaccines are quadrivalent, rather than trivalent. This means flu shots will contain four vaccine strain influenza viruses — two influenza A viruses and two influenza B viruses.

Gen Z Wants to ‘Wait a Little Bit’ to Get COVID Vaccine. Experts Say There’s No Time to Waste

USA Today via MSN reported:

Patricia Smithson, 23, thought about her aunt in New York who died alone of COVID-19 when she decided to get her vaccine. Gracie Poynter, 21, knows her concerns about the safety of the shots could jeopardize her job in health care.

They’re all part of a group once considered a low priority in the nation’s vaccine rollout: Generation Z, loosely defined as those in their mid-20s and younger. But now that vaccinations are readily available to Americans 12 and older, the nation’s lagging vaccine rate among young adults is raising alarms.

Chicago Public Schools Launches COVID Vaccination Effort

NBC 5 Chicago reported:

Chicago Public Schools launches its COVID-19 vaccination effort this week, transforming three high schools into clinics to inoculate students before the new school year begins in the fall.

Officials with the nation’s third-largest school district plan to offer full in-person instruction in the fall and want to vaccinate as many students as possible before classes begin next month. District officials said they are “not in a position” to mandate COVID-19 vaccines, but will ask families to submit COVID-19 vaccine documents as is the practice with other vaccinations.

19 Words From Moderna’s CEO That May Guarantee Billions in Revenue for the Long Term

MSN reported:

Investors have been cheering about Moderna’s (NASDAQ: MRNA) ability to bring a coronavirus vaccine to market in less than a year — and post more than a billion dollars in profit in the first full quarter of sales. The stock climbed 434% last year. And in the first half of 2021 it advanced 125%.

The one worry many have is this: Will the big-time revenue be recurrent? Or will it diminish in a post-pandemic world? Experts say the coronavirus is here to stay. Still, if the virus weakens or becomes less widespread, people may not rush out for an annual COVID-19 vaccination.

Republicans Push to Ban ‘Discrimination’ Against Unvaccinated People

Axios reported:

State Republican lawmakers around the country are pushing bills — at least one of which has become law — that would give unvaccinated people the same protections as those surrounding race, gender and religion.

Why it matters: These bills would tie the hands of private businesses that want to protect their employees and customers. But they also show how deep into the political psyche resistance to coronavirus vaccine requirements has become, and how vaccination status has rapidly become a marker of identity.

Bipartisan Majority of Americans Now Believe Coronavirus Leaked From Lab: Poll

National Review reported:

A majority of Americans now believe that the novel coronavirus leaked from a laboratory, according to a poll by Politico and Harvard University.

The survey found that 52 percent of Americans believe coronavirus leaked from a lab, compared with 28 percent who think the pandemic started following human contact with an infected animal. Support for the lab-leak theory is bipartisan, with 52 percent of Democrat and 59 percent of Republican respondents backing the theory.

Israel Starts Administering Third Dose of Pfizer Vaccine to At-Risk Adults

The Washington Post via MSN reported:

Israel’s Ministry of Health on Monday began offering a third dose of the Pfizer vaccine to severely immunocompromised adults in what health experts say could be the first phase of an experiment to provide coronavirus booster shots for older people and the most vulnerable.

The recommendation, published Sunday by the ministry, said that the goal of the new program was to raise antibody levels among immunocompromised citizens, including cancer patients, recipients of liver transplants, and others who have recently exhibited weakened vaccine protection, according to data. It said that it had still not made a decision on administering third shots for the general adult population.

Woman Dies After First Dose of AstraZeneca Vaccine

Yahoo!News reported:

A 72-year-old Adelaide woman has died after she developed blood clots following administration of the AstraZeneca vaccine.

“Obviously this is a very sad situation,” SA Premier Steven Marshall said on Monday, saying the woman died in the Royal Adelaide Hospital overnight.

The woman had received her first vaccine dose on June 24 and was admitted to the hospital on July 5. She spent several days in the ICU.

Long Shot Patients With Long COVID to Receive Monthly Vaccines in Trial in Cure Hope As 1 in 10 With Bug Suffer Chronic Symptoms

The Sun reported:

In a world-first, British scientists are set to explore giving sufferers monthly doses of the vaccine in a bid to combat the condition.

After winning the go-ahead on Friday, 40 long COVID sufferers will be offered at least two extra jabs in a trial later this year.

Several of the major vaccine developers are backing the study and if the pilot is successful the scientists can recruit thousands more patients.

Family Demand Answers as Father-of-Two, 57, Fights for Life on Ventilator With Potentially Deadly Guillain-Barré Syndrome After Having AstraZeneca COVID Jab

The Daily Mail reported:

The family of a father-of-two are demanding answers while he fights for his life with a potentially fatal syndrome after having the AstraZeneca COVID jab.

Anthony Shingler, 57, from Northwood in Stoke-on-Trent, was left ‘paralysed’ after having his first dose of the jab three months ago in March.

He has since been diagnosed with Guillain-Barré syndrome which is a very rare and serious condition that affects the body’s nerves.